KEGG   PATHWAY: aml05200
Entry
aml05200                    Pathway                                
Name
Pathways in cancer - Ailuropoda melanoleuca (giant panda)
Class
Human Diseases; Cancer: overview
Pathway map
aml05200  Pathways in cancer
aml05200

Organism
Ailuropoda melanoleuca (giant panda) [GN:aml]
Gene
105235553  DCC; netrin receptor DCC isoform X1 [KO:K06765]
100469056  CASP3; caspase-3 isoform X1 [KO:K02187] [EC:3.4.22.56]
100483760  CASP9; caspase-9 [KO:K04399] [EC:3.4.22.62]
100463883  APPL1; DCC-interacting protein 13-alpha isoform X1 [KO:K08733]
100475573  CDH1; cadherin-1 [KO:K05689]
105240970  LOW QUALITY PROTEIN: cadherin-1 [KO:K05689]
100477834  CTNNB1; catenin beta-1 [KO:K02105]
100483944  CTNNA1; catenin alpha-1 [KO:K05691]
100470940  catenin alpha-2 isoform X1 [KO:K05691]
105241995  catenin alpha-2 [KO:K05691]
105234678  CTNNA3; catenin alpha-3 [KO:K05691]
100473018  AXIN1; axin-1 isoform X1 [KO:K02157]
100477069  AXIN2; axin-2 isoform X1 [KO:K04385]
100472257  APC; adenomatous polyposis coli protein isoform X5 [KO:K02085]
100465768  APC2; LOW QUALITY PROTEIN: adenomatous polyposis coli protein 2 [KO:K02085]
100479224  GSK3B; glycogen synthase kinase-3 beta isoform X2 [KO:K03083] [EC:2.7.11.26]
100476528  TCF7; transcription factor 7 isoform X2 [KO:K02620]
100480690  TCF7L1; transcription factor 7-like 1 [KO:K04490]
100467719  TCF7L2; transcription factor 7-like 2 isoform X6 [KO:K04491]
100465982  LEF1; lymphoid enhancer-binding factor 1 isoform X2 [KO:K04492]
100475314  BIRC5; baculoviral IAP repeat-containing protein 5 [KO:K08731]
100464396  MYC; myc proto-oncogene protein [KO:K04377]
100469787  CCND1; G1/S-specific cyclin-D1 isoform X1 [KO:K04503]
100475007  WNT1; proto-oncogene Wnt-1 [KO:K03209]
100480237  WNT2; protein Wnt-2 isoform X1 [KO:K00182]
100481665  WNT2B; protein Wnt-2b isoform X1 [KO:K00182]
100471555  WNT3; proto-oncogene Wnt-3 [KO:K00312]
100473835  WNT3A; protein Wnt-3a [KO:K00312]
100468584  WNT4; protein Wnt-4 [KO:K00408]
100484068  WNT5A; protein Wnt-5a isoform X1 [KO:K00444]
100473854  WNT5B; protein Wnt-5b isoform X3 [KO:K00444]
100467896  WNT6; protein Wnt-6 [KO:K00445]
100475153  WNT7A; protein Wnt-7a isoform X1 [KO:K00572]
100474982  WNT7B; protein Wnt-7b [KO:K00572]
100466672  WNT8B; protein Wnt-8b isoform X1 [KO:K00714]
100481684  WNT8A; LOW QUALITY PROTEIN: protein Wnt-8a [KO:K00714]
100472460  WNT9B; protein Wnt-9b [KO:K01064]
100475103  WNT9A; protein Wnt-9a isoform X1 [KO:K01064]
100467643  protein Wnt-10a isoform X1 [KO:K01357]
100475265  WNT10B; protein Wnt-10b isoform X1 [KO:K01357]
117795031  WNT10A; LOW QUALITY PROTEIN: protein Wnt-10a [KO:K01357]
100468561  WNT11; protein Wnt-11 [KO:K01384]
100464171  WNT16; protein Wnt-16 isoform X1 [KO:K01558]
100469196  FZD1; frizzled-1 [KO:K02432]
109489608  FZD7; frizzled-7 [KO:K02432]
100469249  FZD2; frizzled-2 [KO:K02235]
100468831  FZD3; frizzled-3 isoform X1 [KO:K02329]
100470379  FZD4; frizzled-4 [KO:K02354]
100478649  FZD5; frizzled-5 [KO:K02375]
100467779  FZD8; frizzled-8 [KO:K02375]
100464621  FZD6; frizzled-6 isoform X1 [KO:K02376]
100479765  FZD10; frizzled-10 [KO:K02842]
100469765  FZD9; LOW QUALITY PROTEIN: frizzled-9 [KO:K02842]
100473379  LRP5; LOW QUALITY PROTEIN: low-density lipoprotein receptor-related protein 5 [KO:K03068]
100477840  LRP6; low-density lipoprotein receptor-related protein 6 isoform X1 [KO:K03068]
100466067  DVL3; segment polarity protein dishevelled homolog DVL-3 [KO:K02353]
100471972  DVL1; segment polarity protein dishevelled homolog DVL-1 isoform X2 [KO:K02353]
100480005  DVL2; segment polarity protein dishevelled homolog DVL-2 isoform X1 [KO:K02353]
105236609  FRAT1; proto-oncogene FRAT1 [KO:K03069]
117802815  FRAT2; GSK-3-binding protein FRAT2 [KO:K03096]
100472871  F2; prothrombin [KO:K01313] [EC:3.4.21.5]
100470137  AGT; angiotensinogen [KO:K09821]
105240499  F2R; proteinase-activated receptor 1 [KO:K03914]
100469728  F2RL3; proteinase-activated receptor 4 isoform X1 [KO:K04236]
100479569  LPAR1; lysophosphatidic acid receptor 1 [KO:K04289]
100483313  LPAR2; lysophosphatidic acid receptor 2 [KO:K04291]
100474288  LPAR3; lysophosphatidic acid receptor 3 isoform X1 [KO:K04294]
100477865  LPAR4; lysophosphatidic acid receptor 4 [KO:K04275]
100477983  LPAR5; lysophosphatidic acid receptor 5 [KO:K08390]
100475559  LPAR6; lysophosphatidic acid receptor 6 [KO:K04273]
100471220  AGTR1; type-1 angiotensin II receptor [KO:K04166]
100465369  GNA12; guanine nucleotide-binding protein subunit alpha-12 isoform X1 [KO:K04346]
100474482  GNA13; guanine nucleotide-binding protein subunit alpha-13 [KO:K04639]
100471078  ARHGEF12; rho guanine nucleotide exchange factor 12 isoform X1 [KO:K07532]
100474673  ARHGEF11; LOW QUALITY PROTEIN: rho guanine nucleotide exchange factor 11 [KO:K12331]
100477081  ARHGEF1; rho guanine nucleotide exchange factor 1 isoform X1 [KO:K12330]
100472277  PLEKHG5; pleckstrin homology domain-containing family G member 5 isoform X1 [KO:K19464]
100476723  RHOA; transforming protein RhoA [KO:K04513]
100474469  ROCK1; rho-associated protein kinase 1 isoform X1 [KO:K04514] [EC:2.7.11.1]
100466003  ROCK2; rho-associated protein kinase 2 isoform X1 [KO:K17388] [EC:2.7.11.1]
100482629  CXCL12; stromal cell-derived factor 1 isoform X2 [KO:K10031]
100468194  CXCR4; C-X-C chemokine receptor type 4 [KO:K04189]
100471767  GNAI2; guanine nucleotide-binding protein G(i) subunit alpha-2 [KO:K04630]
100484933  GNAI1; guanine nucleotide-binding protein G(i) subunit alpha-1 [KO:K04630]
100466408  GNAI3; guanine nucleotide-binding protein G(i) subunit alpha [KO:K04630]
105238442  PTGER1; prostaglandin E2 receptor EP1 subtype [KO:K04258]
100479883  PTGER2; prostaglandin E2 receptor EP2 subtype isoform X1 [KO:K04259]
100480537  PTGER3; prostaglandin E2 receptor EP3 subtype isoform X2 [KO:K04260]
100470778  PTGER4; prostaglandin E2 receptor EP4 subtype [KO:K04261]
100473680  guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas isoform X1 [KO:K04632]
100469231  neuroendocrine secretory protein 55 [KO:K04632]
100472777  ADCY1; adenylate cyclase type 1 [KO:K08041] [EC:4.6.1.1]
100473195  ADCY2; adenylate cyclase type 2 [KO:K08042] [EC:4.6.1.1]
100471164  ADCY3; adenylate cyclase type 3 isoform X2 [KO:K08043] [EC:4.6.1.1]
100471940  ADCY4; adenylate cyclase type 4 isoform X1 [KO:K08044] [EC:4.6.1.1]
100482519  ADCY5; adenylate cyclase type 5 [KO:K08045] [EC:4.6.1.1]
100476922  ADCY6; adenylate cyclase type 6 isoform X2 [KO:K08046] [EC:4.6.1.1]
100466965  ADCY7; adenylate cyclase type 7 isoform X1 [KO:K08047] [EC:4.6.1.1]
100474121  ADCY8; adenylate cyclase type 8 [KO:K08048] [EC:4.6.1.1]
100476495  ADCY9; adenylate cyclase type 9 [KO:K08049] [EC:4.6.1.1]
100468252  PRKACA; cAMP-dependent protein kinase catalytic subunit alpha isoform X2 [KO:K04345] [EC:2.7.11.11]
100469628  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
100474825  GNB1; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 [KO:K04536]
100484553  GNB2; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 [KO:K04537]
100475485  GNB3; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 isoform X1 [KO:K07825]
100480040  GNB4; guanine nucleotide-binding protein subunit beta-4 [KO:K04538]
100467255  GNB5; guanine nucleotide-binding protein subunit beta-5 [KO:K04539]
100482029  GNG2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 [KO:K07826]
100483209  GNG3; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 [KO:K04540]
100468197  GNG4; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 [KO:K04541]
100476938  GNG5; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 [KO:K04542]
100483125  GNG7; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 [KO:K04543]
100471622  GNG8; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8 [KO:K04544]
105236417  GNG10; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 [KO:K04545]
105236905  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10-like [KO:K04545]
100475394  GNG11; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 [KO:K04546]
100477221  GNG14; putative guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-14 [KO:K04347]
100477225  GNG12; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 isoform X1 [KO:K04347]
100476214  GNG13; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13 [KO:K04547]
100475635  GNGT1; guanine nucleotide-binding protein G(T) subunit gamma-T1 [KO:K04548]
100476550  GNGT2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 [KO:K04549]
100478914  COL4A4; collagen alpha-4(IV) chain isoform X1 [KO:K06237]
100478752  COL4A1; collagen alpha-1(IV) chain isoform X4 [KO:K06237]
100479004  COL4A2; collagen alpha-2(IV) chain [KO:K06237]
100479688  COL4A6; collagen alpha-6(IV) chain isoform X1 [KO:K06237]
100480195  COL4A5; collagen alpha-5(IV) chain isoform X1 [KO:K06237]
100478660  COL4A3; collagen alpha-3(IV) chain [KO:K06237]
100484712  LAMA2; laminin subunit alpha-2 isoform X1 [KO:K05637]
100465830  LAMA1; laminin subunit alpha-1 [KO:K05637]
100484669  LAMA3; laminin subunit alpha-3 isoform X3 [KO:K06240]
100482780  LAMA5; laminin subunit alpha-5 [KO:K06240]
100472419  LAMA4; laminin subunit alpha-4 isoform X1 [KO:K06241]
100472572  LAMB1; laminin subunit beta-1 isoform X1 [KO:K05636]
100477974  LAMB2; laminin subunit beta-2 [KO:K06243]
100465597  LAMB3; laminin subunit beta-3 isoform X2 [KO:K06244]
100477380  LAMB4; laminin subunit beta-4 isoform X1 [KO:K06245]
100476326  LAMC1; laminin subunit gamma-1 [KO:K05635]
100475077  LAMC2; laminin subunit gamma-2 [KO:K06246]
100477198  LAMC3; laminin subunit gamma-3 [KO:K06247]
100464134  FN1; fibronectin isoform X1 [KO:K05717]
100476403  ITGA2; integrin alpha-2 [KO:K06481]
100484185  ITGA2B; integrin alpha-IIb [KO:K06476]
100479748  ITGA3; integrin alpha-3 [KO:K06482]
100474079  ITGA6; integrin alpha-6 isoform X1 [KO:K06485]
100483894  ITGAV; integrin alpha-V isoform X1 [KO:K06487]
100482697  ITGB1; integrin beta-1 isoform X1 [KO:K05719]
100464496  PTK2; focal adhesion kinase 1 isoform X1 [KO:K05725] [EC:2.7.10.2]
100463775  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
100479294  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
100479580  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922] [EC:2.7.1.153]
100475291  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
100483828  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
100467916  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649]
100469483  PTEN; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X2 [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
105235627  NKX3-1; homeobox protein Nkx-3.1 [KO:K09348]
100468763  AKT2; RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
100480414  AKT3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
100465793  AKT1; RAC-alpha serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
100464675  CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha isoform X1 [KO:K04467] [EC:2.7.11.10]
100471679  IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [KO:K07209] [EC:2.7.11.10]
100470223  IKBKG; NF-kappa-B essential modulator isoform X1 [KO:K07210]
100466997  NFKBIA; NF-kappa-B inhibitor alpha [KO:K04734]
100467906  NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
100474781  NFKB2; nuclear factor NF-kappa-B p100 subunit isoform X2 [KO:K04469]
100480158  RELA; transcription factor p65 isoform X1 [KO:K04735]
100481615  PTGS2; prostaglandin G/H synthase 2 [KO:K11987] [EC:1.14.99.1]
100470060  NOS2; nitric oxide synthase, inducible [KO:K13241] [EC:1.14.13.39]
100484344  BCL2; LOW QUALITY PROTEIN: apoptosis regulator Bcl-2 [KO:K02161]
100477152  baculoviral IAP repeat-containing protein 3 isoform X1 [KO:K16060]
100477406  baculoviral IAP repeat-containing protein 2 [KO:K16060]
100471203  XIAP; E3 ubiquitin-protein ligase XIAP [KO:K04725] [EC:2.3.2.27]
100483031  BIRC7; baculoviral IAP repeat-containing protein 7 [KO:K16061]
100469922  BCL2L1; bcl-2-like protein 1 isoform X1 [KO:K04570]
100464979  TRAF1; TNF receptor-associated factor 1 isoform X1 [KO:K03172]
100474087  TRAF2; TNF receptor-associated factor 2 [KO:K03173] [EC:2.3.2.27]
100466406  TRAF3; TNF receptor-associated factor 3 isoform X1 [KO:K03174]
100464464  TRAF4; TNF receptor-associated factor 4 [KO:K09848]
100475872  TRAF5; TNF receptor-associated factor 5 isoform X2 [KO:K09849]
100483216  TRAF6; TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
100471122  MTOR; serine/threonine-protein kinase mTOR [KO:K07203] [EC:2.7.11.1]
100484786  RPS6KB1; ribosomal protein S6 kinase beta-1 isoform X1 [KO:K04688] [EC:2.7.11.1]
100464998  RPS6KB2; ribosomal protein S6 kinase beta-2 isoform X1 [KO:K04688] [EC:2.7.11.1]
100473937  BAD; bcl2-associated agonist of cell death [KO:K02158]
100471182  FOXO1; LOW QUALITY PROTEIN: forkhead box protein O1 [KO:K07201]
100479481  MDM2; E3 ubiquitin-protein ligase Mdm2 isoform X1 [KO:K06643] [EC:2.3.2.27]
100468516  TP53; cellular tumor antigen p53 [KO:K04451]
100467824  CDKN1B; cyclin-dependent kinase inhibitor 1B [KO:K06624]
100484923  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
100468203  BCR; breakpoint cluster region protein [KO:K08878] [EC:2.7.11.1]
100466468  ABL1; tyrosine-protein kinase ABL1 isoform X1 [KO:K06619] [EC:2.7.10.2]
100466609  CRKL; crk-like protein [KO:K04438]
100467322  CRK; adapter molecule crk isoform X1 [KO:K04438]
100470573  CBL; E3 ubiquitin-protein ligase CBL isoform X1 [KO:K04707] [EC:2.3.2.27]
100469683  signal transducer and activator of transcription 5A [KO:K11223]
100479246  signal transducer and activator of transcription 5B [KO:K11224]
100464765  PIM1; serine/threonine-protein kinase pim-1 [KO:K04702] [EC:2.7.11.1]
100478219  PIM2; serine/threonine-protein kinase pim-2 isoform X2 [KO:K08806] [EC:2.7.11.1]
100482228  KNG1; kininogen-1 [KO:K03898]
100470926  EDN1; endothelin-1 [KO:K16366]
100482893  BDKRB1; B1 bradykinin receptor [KO:K03915]
100482647  BDKRB2; B2 bradykinin receptor [KO:K03916]
100474277  EDNRA; endothelin-1 receptor [KO:K04197]
100465526  EDNRB; endothelin receptor type B [KO:K04198]
100464853  GNAQ; guanine nucleotide-binding protein G(q) subunit alpha [KO:K04634]
100469689  GNA11; guanine nucleotide-binding protein subunit alpha-11 [KO:K04635]
100481755  PLCB1; LOW QUALITY PROTEIN: 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 [KO:K05858] [EC:3.1.4.11]
100480603  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 [KO:K05858] [EC:3.1.4.11]
100465232  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 [KO:K05858] [EC:3.1.4.11]
100474779  PLCB2; LOW QUALITY PROTEIN: 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 [KO:K05858] [EC:3.1.4.11]
100477326  PRKCA; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
100478007  PRKCB; protein kinase C beta type isoform X2 [KO:K19662] [EC:2.7.11.13]
100484719  PRKCG; protein kinase C gamma type isoform X1 [KO:K19663] [EC:2.7.11.13]
100480862  IL2; interleukin-2 precursor [KO:K05429]
100473242  interleukin-3 [KO:K04736]
100482473  IL4; interleukin-4 precursor [KO:K05430]
100482219  IL5; interleukin-5 [KO:K05428]
100477151  IL6; interleukin-6 precursor [KO:K05405]
117803984  interleukin-6-like [KO:K05405]
100481194  IL7; interleukin-7 [KO:K05431]
100470471  IL12A; interleukin-12 subunit alpha isoform X2 [KO:K05406]
100477772  IL12B; interleukin-12 subunit beta [KO:K05425]
100474520  IL13; LOW QUALITY PROTEIN: interleukin-13 [KO:K05435]
100484790  IL15; interleukin-15 precursor [KO:K05433]
100471919  IL23A; interleukin-23 subunit alpha [KO:K05426]
100483785  EPO; erythropoietin [KO:K05437]
100476812  interferon alpha-2 [KO:K05414]
100477312  interferon alpha-1/2 [KO:K05414]
100477562  LOW QUALITY PROTEIN: interferon alpha-1/2 [KO:K05414]
100478321  interferon alpha-1/2 [KO:K05414]
100478068  interferon alpha-like [KO:K05414]
100462659  IFNG; interferon gamma precursor [KO:K04687]
100466247  IL2RA; interleukin-2 receptor subunit alpha isoform X3 [KO:K05068]
100478292  IL2RB; interleukin-2 receptor subunit beta [KO:K05069]
100468126  IL2RG; cytokine receptor common subunit gamma isoform X2 [KO:K05070]
105238362  IL3RA; interleukin-3 receptor subunit alpha [KO:K04737]
100476095  IL4R; interleukin-4 receptor subunit alpha isoform X1 [KO:K05071]
100477536  CSF2RB; cytokine receptor common subunit beta [KO:K04738]
100478972  IL5RA; interleukin-5 receptor subunit alpha [KO:K05067]
100471277  IL6R; interleukin-6 receptor subunit alpha isoform X1 [KO:K05055]
100483131  IL6ST; interleukin-6 receptor subunit beta isoform X1 [KO:K05060]
100477617  IL7R; interleukin-7 receptor subunit alpha [KO:K05072]
100474774  IL12RB1; interleukin-12 receptor subunit beta-1 isoform X2 [KO:K05063]
100478166  IL12RB2; interleukin-12 receptor subunit beta-2 isoform X2 [KO:K05064]
100477299  IL13RA1; interleukin-13 receptor subunit alpha-1 [KO:K05076]
105238122  IL15RA; interleukin-15 receptor subunit alpha isoform X1 [KO:K05074]
100478419  IL23R; interleukin-23 receptor [KO:K05065]
100484014  EPOR; erythropoietin receptor [KO:K05079]
100481921  IFNAR1; interferon alpha/beta receptor 1 [KO:K05130]
100482679  IFNAR2; interferon alpha/beta receptor 2 [KO:K05131]
100473768  IFNGR1; interferon gamma receptor 1 [KO:K05132]
100481672  IFNGR2; interferon gamma receptor 2 isoform X1 [KO:K05133]
100475514  EML4; echinoderm microtubule-associated protein-like 4 isoform X1 [KO:K15420]
100473389  ALK; ALK tyrosine kinase receptor isoform X1 [KO:K05119] [EC:2.7.10.1]
100483012  RASGRP1; RAS guanyl-releasing protein 1 isoform X1 [KO:K04350]
105236463  RASGRP2; RAS guanyl-releasing protein 2 isoform X1 [KO:K12361]
100484622  RASGRP3; ras guanyl-releasing protein 3 isoform X1 [KO:K12362]
100471293  RASGRP4; RAS guanyl-releasing protein 4 isoform X1 [KO:K12363]
100473460  JAK1; tyrosine-protein kinase JAK1 isoform X2 [KO:K11217] [EC:2.7.10.2]
100481360  JAK2; tyrosine-protein kinase JAK2 isoform X1 [KO:K04447] [EC:2.7.10.2]
100474005  JAK3; tyrosine-protein kinase JAK3 isoform X1 [KO:K11218] [EC:2.7.10.2]
100469938  STAT3; signal transducer and activator of transcription 3 isoform X1 [KO:K04692]
100474026  STAT1; signal transducer and activator of transcription 1-alpha/beta [KO:K11220]
100472167  STAT2; signal transducer and activator of transcription 2 isoform X1 [KO:K11221]
100471596  STAT4; signal transducer and activator of transcription 4 isoform X3 [KO:K11222]
100476198  STAT6; signal transducer and activator of transcription 6 isoform X1 [KO:K11225]
100482983  VEGFA; vascular endothelial growth factor A [KO:K05448]
100465735  VEGFB; vascular endothelial growth factor B [KO:K16858]
100480980  PGF; placenta growth factor isoform X1 [KO:K16859]
100482213  VEGFD; vascular endothelial growth factor D isoform X1 [KO:K05449]
100483046  VEGFC; vascular endothelial growth factor C [KO:K05449]
100467724  TGFA; protransforming growth factor alpha isoform X3 [KO:K08774]
100467733  pro-epidermal growth factor isoform X1 [KO:K04357]
100480029  ERBB2; receptor tyrosine-protein kinase erbB-2 [KO:K05083] [EC:2.7.10.1]
100473486  PDGFA; platelet-derived growth factor subunit A isoform X1 [KO:K04359]
100475543  PDGFB; platelet-derived growth factor subunit B isoform X4 [KO:K17386]
100464991  PDGFRA; platelet-derived growth factor receptor alpha isoform X1 [KO:K04363] [EC:2.7.10.1]
100472005  PDGFRB; LOW QUALITY PROTEIN: platelet-derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]
100473254  IGF1; insulin-like growth factor I isoform X3 [KO:K05459]
100483184  insulin-like growth factor II isoform X1 [KO:K13769]
100471374  IGF1R; insulin-like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]
100469856  KITLG; kit ligand isoform X1 [KO:K05461]
100465243  KIT; mast/stem cell growth factor receptor Kit isoform X1 [KO:K05091] [EC:2.7.10.1]
100483963  FLT3; receptor-type tyrosine-protein kinase FLT3 [KO:K05092] [EC:2.7.10.1]
100463560  HGF; hepatocyte growth factor isoform X5 [KO:K05460]
100480742  MET; hepatocyte growth factor receptor isoform X2 [KO:K05099] [EC:2.7.10.1]
100463878  FGF1; fibroblast growth factor 1 isoform X1 [KO:K18496]
100479986  FGF2; LOW QUALITY PROTEIN: fibroblast growth factor 2 [KO:K18497]
100482817  FGF8; fibroblast growth factor 8 [KO:K04358]
100474108  FGF17; fibroblast growth factor 17 isoform X1 [KO:K04358]
100468641  FGF5; fibroblast growth factor 5 isoform X1 [KO:K04358]
100467527  FGF20; fibroblast growth factor 20 [KO:K04358]
100479573  FGF7; fibroblast growth factor 7 isoform X1 [KO:K04358]
100464088  FGF18; fibroblast growth factor 18 isoform X2 [KO:K04358]
100470803  fibroblast growth factor 3 [KO:K04358]
100471023  FGF6; fibroblast growth factor 6 [KO:K04358]
100473739  FGF9; fibroblast growth factor 9 [KO:K04358]
100466947  FGF16; fibroblast growth factor 16 [KO:K04358]
100475745  FGF10; fibroblast growth factor 10 [KO:K04358]
100481939  FGF22; fibroblast growth factor 22 isoform X2 [KO:K04358]
100470300  FGF19; fibroblast growth factor 19 [KO:K22603]
100478145  FGF21; fibroblast growth factor 21 [KO:K22429]
100472512  FGF23; fibroblast growth factor 23 [KO:K22428]
100472630  FGFR1; fibroblast growth factor receptor 1 isoform X1 [KO:K04362] [EC:2.7.10.1]
100468267  FGFR2; fibroblast growth factor receptor 2 [KO:K05093] [EC:2.7.10.1]
100481826  FGFR3; fibroblast growth factor receptor 3 isoform X1 [KO:K05094] [EC:2.7.10.1]
100477678  FGFR4; fibroblast growth factor receptor 4 [KO:K05095] [EC:2.7.10.1]
100468916  GRB2; growth factor receptor-bound protein 2 isoform X1 [KO:K04364]
100474396  SOS2; son of sevenless homolog 2 isoform X9 [KO:K03099]
100482526  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
100473836  HRAS; GTPase HRas isoform X1 [KO:K02833]
100483919  KRAS; GTPase KRas isoform X1 [KO:K07827]
100464196  NRAS; GTPase NRas [KO:K07828]
100475955  ARAF; serine/threonine-protein kinase A-Raf [KO:K08845] [EC:2.7.11.1]
100469346  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
100482255  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
100478039  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
100465700  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
100470035  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
100472388  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
100483834  JUN; transcription factor AP-1 [KO:K04448]
100474867  FOS; proto-oncogene c-Fos [KO:K04379]
100469300  ETS1; protein C-ets-1 isoform X3 [KO:K02678]
100478167  MMP1; LOW QUALITY PROTEIN: interstitial collagenase [KO:K01388] [EC:3.4.24.7]
100481181  LOW QUALITY PROTEIN: interstitial collagenase [KO:K01388] [EC:3.4.24.7]
100476183  MMP2; 72 kDa type IV collagenase isoform X1 [KO:K01398] [EC:3.4.24.24]
100475429  MMP9; matrix metalloproteinase-9 [KO:K01403] [EC:3.4.24.35]
100472054  CXCL8; interleukin-8 [KO:K10030]
100481236  CDK4; cyclin-dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
100482684  RPS6KA5; ribosomal protein S6 kinase alpha-5 isoform X1 [KO:K04445] [EC:2.7.11.1]
100467317  RET; proto-oncogene tyrosine-protein kinase receptor Ret isoform X1 [KO:K05126] [EC:2.7.10.1]
100476794  CCDC6; LOW QUALITY PROTEIN: coiled-coil domain-containing protein 6 [KO:K09288]
100474916  NCOA4; nuclear receptor coactivator 4 isoform X1 [KO:K09289]
100482767  TPM3; tropomyosin alpha-3 chain isoform X7 [KO:K09290]
117799607  tropomyosin alpha-3 chain-like [KO:K09290]
100480868  TPR; nucleoprotein TPR isoform X5 [KO:K09291]
100466561  TFG; protein TFG isoform X1 [KO:K09292]
100480849  RASSF1; ras association domain-containing protein 1 isoform X1 [KO:K09850]
100465364  RASSF5; ras association domain-containing protein 5 [KO:K08015]
100466725  STK4; serine/threonine-protein kinase 4 isoform X1 [KO:K04411]
100476424  DAPK1; LOW QUALITY PROTEIN: death-associated protein kinase 1 [KO:K08803] [EC:2.7.11.1]
100471255  DAPK2; death-associated protein kinase 2 isoform X1 [KO:K08803] [EC:2.7.11.1]
100471455  DAPK3; death-associated protein kinase 3 [KO:K08803] [EC:2.7.11.1]
100480586  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X2 [KO:K01116] [EC:3.1.4.11]
100481994  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X1 [KO:K05859] [EC:3.1.4.11]
100481494  ELK1; ETS domain-containing protein Elk-1 isoform X2 [KO:K04375]
100478600  CALML6; calmodulin-like protein 6 [KO:K02183]
100470909  CALM2; calmodulin-2 [KO:K02183]
100484519  calmodulin [KO:K02183]
100484770  calmodulin-like protein 3 [KO:K02183]
100481177  CALM1; calmodulin-1 [KO:K02183]
100472122  CALM3; calmodulin-3 [KO:K02183]
100478732  CALML4; LOW QUALITY PROTEIN: calmodulin-like protein 4 [KO:K02183]
117799706  calmodulin-alpha-like [KO:K02183]
100475467  CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X2 [KO:K04515] [EC:2.7.11.17]
100466256  CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X5 [KO:K04515] [EC:2.7.11.17]
100474459  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X3 [KO:K04515] [EC:2.7.11.17]
100478243  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta [KO:K04515] [EC:2.7.11.17]
100472281  LOW QUALITY PROTEIN: ral guanine nucleotide dissociation stimulator [KO:K08732]
100484672  RALA; ras-related protein Ral-A [KO:K07834]
100481993  RALB; ras-related protein Ral-B [KO:K07835]
100478485  RALBP1; ralA-binding protein 1 [KO:K08773]
100465076  CDC42; cell division control protein 42 homolog isoform X1 [KO:K04393]
100465648  RAC1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
100469737  RAC2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
100468971  RAC3; ras-related C3 botulinum toxin substrate 3 isoform X1 [KO:K07861]
100477588  PLD2; phospholipase D2 [KO:K01115] [EC:3.1.4.4]
100484111  PLD1; phospholipase D1 isoform X1 [KO:K01115] [EC:3.1.4.4]
100477951  MAPK10; mitogen-activated protein kinase 10 isoform X1 [KO:K04440] [EC:2.7.11.24]
100482196  MAPK8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
100477600  MAPK9; mitogen-activated protein kinase 9 isoform X2 [KO:K04440] [EC:2.7.11.24]
100480115  paired box protein Pax-8 [KO:K09293]
100482938  PPARG; peroxisome proliferator-activated receptor gamma isoform X1 [KO:K08530]
100479839  RXRA; retinoic acid receptor RXR-alpha [KO:K08524]
100475696  RXRB; retinoic acid receptor RXR-beta isoform X2 [KO:K08525]
100475450  RXRG; retinoic acid receptor RXR-gamma isoform X1 [KO:K08526]
100468872  RARB; retinoic acid receptor beta isoform X2 [KO:K08528]
100484518  ESR1; estrogen receptor isoform X1 [KO:K08550]
100471498  ESR2; estrogen receptor beta [KO:K08551]
100471908  NCOA1; nuclear receptor coactivator 1 isoform X1 [KO:K09101] [EC:2.3.1.48]
100482382  NCOA3; nuclear receptor coactivator 3 isoform X1 [KO:K11256] [EC:2.3.1.48]
100474983  SP1; transcription factor Sp1 [KO:K04684]
100466714  PPARD; peroxisome proliferator-activated receptor delta [KO:K04504]
100466345  JUP; junction plakoglobin [KO:K10056]
100476757  ZBTB16; zinc finger and BTB domain-containing protein 16 [KO:K10055]
100463678  RARA; retinoic acid receptor alpha isoform X3 [KO:K08527]
100482271  CCNA2; cyclin-A2 [KO:K06627]
100475180  CCNA1; cyclin-A1 [KO:K06627]
100475070  PML; protein PML isoform X1 [KO:K10054] [EC:2.3.2.-]
100484679  RUNX1; runt-related transcription factor 1 isoform X1 [KO:K08367]
100478720  RUNX1T1; protein CBFA2T1 isoform X4 [KO:K10053]
100476314  SPI1; transcription factor PU.1 isoform X3 [KO:K09438]
100469640  CEBPA; CCAAT/enhancer-binding protein alpha [KO:K09055]
100469756  CSF2RA; granulocyte-macrophage colony-stimulating factor receptor subunit alpha [KO:K05066]
105238364  granulocyte-macrophage colony-stimulating factor receptor subunit alpha-like [KO:K05066]
100464681  CSF3R; granulocyte colony-stimulating factor receptor [KO:K05061]
100472252  CSF1R; macrophage colony-stimulating factor 1 receptor isoform X2 [KO:K05090] [EC:2.7.10.1]
100472171  cyclin-dependent kinase inhibitor 2A isoform X3 [KO:K06621]
117795744  E2F1; transcription factor E2F1 [KO:K17454]
100475779  E2F2; transcription factor E2F2 isoform X1 [KO:K09389]
100484544  E2F3; transcription factor E2F3 [KO:K06620]
100468226  MAX; protein max isoform X2 [KO:K04453]
100482510  ZBTB17; zinc finger and BTB domain-containing protein 17 [KO:K10500]
100473431  cyclin-dependent kinase 4 inhibitor B [KO:K04685]
100476389  CDK6; cyclin-dependent kinase 6 isoform X2 [KO:K02091] [EC:2.7.11.22]
100471517  CCND2; G1/S-specific cyclin-D2 [KO:K10151]
100479467  CCND3; G1/S-specific cyclin-D3 isoform X4 [KO:K10152]
100480607  CKS1B; cyclin-dependent kinases regulatory subunit 1 isoform X3 [KO:K02219]
117795037  CKS2; cyclin-dependent kinases regulatory subunit 2 [KO:K02219]
117796039  cyclin-dependent kinases regulatory subunit 2 [KO:K02219]
100463880  SKP1; S-phase kinase-associated protein 1 [KO:K03094]
100466596  CUL1; cullin-1 isoform X1 [KO:K03347]
100480437  SKP2; S-phase kinase-associated protein 2 [KO:K03875]
100468314  CDK2; cyclin-dependent kinase 2 isoform X2 [KO:K02206] [EC:2.7.11.22]
100471009  CCNE1; G1/S-specific cyclin-E1 [KO:K06626]
100483627  CCNE2; G1/S-specific cyclin-E2 isoform X1 [KO:K06626]
100477714  RB1; retinoblastoma-associated protein isoform X1 [KO:K06618]
100477654  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha isoform X1 [KO:K04402]
100482871  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
100470600  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
100471095  BAX; apoptosis regulator BAX isoform X1 [KO:K02159]
100472241  BAK1; bcl-2 homologous antagonist/killer [KO:K14021]
100479738  DDB2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
100464732  POLK; DNA polymerase kappa isoform X2 [KO:K03511] [EC:2.7.7.7]
105237456  TERT; telomerase reverse transcriptase [KO:K11126] [EC:2.7.7.49]
100471143  MITF; microphthalmia-associated transcription factor isoform X3 [KO:K09455]
100470703  TGFB1; transforming growth factor beta-1 proprotein isoform X1 [KO:K13375]
100463584  TGFB2; transforming growth factor beta-2 proprotein isoform X2 [KO:K13376]
100475861  TGFB3; transforming growth factor beta-3 proprotein isoform X1 [KO:K13377]
100475698  TGFBR1; TGF-beta receptor type-1 [KO:K04674] [EC:2.7.11.30]
100482939  TGFBR2; TGF-beta receptor type-2 isoform X1 [KO:K04388] [EC:2.7.11.30]
100467069  SMAD2; mothers against decapentaplegic homolog 2 isoform X1 [KO:K04500]
100479304  SMAD3; mothers against decapentaplegic homolog 3 isoform X1 [KO:K23605]
100465063  SMAD4; mothers against decapentaplegic homolog 4 isoform X1 [KO:K04501]
100482997  MECOM; histone-lysine N-methyltransferase MECOM isoform X1 [KO:K04462] [EC:2.1.1.367]
100484032  CTBP1; C-terminal-binding protein 1 isoform X2 [KO:K04496] [EC:1.1.1.428]
100470969  CTBP2; C-terminal-binding protein 2 isoform X1 [KO:K04496] [EC:1.1.1.428]
100477725  HDAC1; histone deacetylase 1 isoform X1 [KO:K06067] [EC:3.5.1.98]
100478424  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]
100476536  MLH1; DNA mismatch repair protein Mlh1 [KO:K08734]
100471735  MSH2; DNA mismatch repair protein Msh2 [KO:K08735]
100475866  MSH3; DNA mismatch repair protein Msh3 isoform X1 [KO:K08736]
100471984  MSH6; DNA mismatch repair protein Msh6 isoform X1 [KO:K08737]
100472854  BRCA2; breast cancer type 2 susceptibility protein isoform X1 [KO:K08775]
100483725  RAD51; DNA repair protein RAD51 homolog 1 isoform X1 [KO:K04482]
100468235  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
100473767  FAS; tumor necrosis factor receptor superfamily member 6 [KO:K04390]
100468003  FADD; FAS-associated death domain protein isoform X1 [KO:K02373]
100472842  CASP8; caspase-8 isoform X1 [KO:K04398] [EC:3.4.22.61]
100465439  BID; BH3-interacting domain death agonist isoform X1 [KO:K04726]
100474991  PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1 [KO:K10131]
100474559  bcl-2-binding component 3, isoforms 1/2 [KO:K10132]
100477763  BCL2L11; bcl-2-like protein 11 isoform X2 [KO:K16341]
100472074  cytochrome c [KO:K08738]
105241648  cytochrome c-like [KO:K08738]
100464163  APAF1; apoptotic protease-activating factor 1 isoform X1 [KO:K02084]
100471992  CASP7; caspase-7 [KO:K04397] [EC:3.4.22.60]
100467923  KEAP1; kelch-like ECH-associated protein 1 [KO:K10456]
100468118  NFE2L2; nuclear factor erythroid 2-related factor 2 isoform X1 [KO:K05638]
100479189  HMOX1; heme oxygenase 1 isoform X1 [KO:K00510] [EC:1.14.14.18]
100475899  NQO1; NAD(P)H dehydrogenase [quinone] 1 isoform X1 [KO:K00355] [EC:1.6.5.2]
100466745  glutathione S-transferase A4 isoform X1 [KO:K00799] [EC:2.5.1.18]
100470076  MGST2; microsomal glutathione S-transferase 2 isoform X1 [KO:K00799] [EC:2.5.1.18]
100471068  glutathione S-transferase A1-like [KO:K00799] [EC:2.5.1.18]
100475941  MGST3; microsomal glutathione S-transferase 3 [KO:K00799] [EC:2.5.1.18]
100476155  GSTT2B; glutathione S-transferase theta-2B [KO:K00799] [EC:2.5.1.18]
100476661  glutathione S-transferase theta-1 [KO:K00799] [EC:2.5.1.18]
100480556  GSTO1; glutathione S-transferase omega-1 [KO:K00799] [EC:2.5.1.18]
100482926  LOW QUALITY PROTEIN: glutathione S-transferase alpha I [KO:K00799] [EC:2.5.1.18]
100483181  glutathione S-transferase Mu 1 [KO:K00799] [EC:2.5.1.18]
100483428  glutathione S-transferase alpha I isoform X1 [KO:K00799] [EC:2.5.1.18]
100483677  GSTM3; glutathione S-transferase Mu 3 isoform X1 [KO:K00799] [EC:2.5.1.18]
100464391  GSTO2; glutathione S-transferase omega-2 [KO:K00799] [EC:2.5.1.18]
100465584  MGST1; microsomal glutathione S-transferase 1 [KO:K00799] [EC:2.5.1.18]
100480698  glutathione S-transferase theta-1 isoform X6 [KO:K00799] [EC:2.5.1.18]
100480947  glutathione S-transferase theta-1-like [KO:K00799] [EC:2.5.1.18]
100476410  glutathione S-transferase theta-4 [KO:K00799] [EC:2.5.1.18]
117801028  glutathione S-transferase Mu 1 isoform X1 [KO:K00799] [EC:2.5.1.18]
100466250  GSTP1; glutathione S-transferase P [KO:K23790] [EC:2.5.1.18]
100466491  glutathione S-transferase P [KO:K23790] [EC:2.5.1.18]
100479058  TXNRD1; thioredoxin reductase 1, cytoplasmic isoform X5 [KO:K22182] [EC:1.8.1.9]
100466258  TXNRD3; thioredoxin reductase 3 [KO:K22182] [EC:1.8.1.9]
100469425  TXNRD2; thioredoxin reductase 2, mitochondrial isoform X3 [KO:K22182] [EC:1.8.1.9]
100473201  VHL; von Hippel-Lindau disease tumor suppressor [KO:K03871]
100468964  ELOC; elongin-C [KO:K03872]
100468275  ELOB; elongin-B [KO:K03873]
100475344  CUL2; cullin-2 [KO:K03870]
100470632  EGLN3; egl nine homolog 3 [KO:K09592] [EC:1.14.11.29]
100465601  EGLN2; egl nine homolog 2 [KO:K09592] [EC:1.14.11.29]
100474374  EGLN1; egl nine homolog 1 [KO:K09592] [EC:1.14.11.29]
100476133  FH; fumarate hydratase, mitochondrial [KO:K01679] [EC:4.2.1.2]
100474777  HIF1A; hypoxia-inducible factor 1-alpha [KO:K08268]
100476273  EPAS1; endothelial PAS domain-containing protein 1 [KO:K09095]
100482504  ARNT; aryl hydrocarbon receptor nuclear translocator isoform X1 [KO:K09097]
100468247  ARNT2; aryl hydrocarbon receptor nuclear translocator 2 isoform X3 [KO:K15589]
100480008  CREBBP; CREB-binding protein isoform X1 [KO:K04498] [EC:2.3.1.48]
100468694  EP300; LOW QUALITY PROTEIN: histone acetyltransferase p300 [KO:K04498] [EC:2.3.1.48]
100476930  SLC2A1; solute carrier family 2, facilitated glucose transporter member 1 [KO:K07299]
100474031  JAG1; protein jagged-1 [KO:K06052]
100465289  JAG2; protein jagged-2 [KO:K21635]
100472990  DLL4; delta-like protein 4 [KO:K06051]
100468026  DLL3; LOW QUALITY PROTEIN: delta-like protein 3 [KO:K06051]
100484708  DLL1; delta-like protein 1 isoform X1 [KO:K06051]
100468934  NOTCH1; neurogenic locus notch homolog protein 1 isoform X1 [KO:K02599]
100464781  NOTCH2; neurogenic locus notch homolog protein 2 isoform X1 [KO:K20994]
100463860  NOTCH3; neurogenic locus notch homolog protein 3 isoform X1 [KO:K20995]
100477609  NOTCH4; neurogenic locus notch homolog protein 4 [KO:K20996]
100481439  HES1; transcription factor HES-1 [KO:K06054]
100468810  HEY2; hairy/enhancer-of-split related with YRPW motif protein 2 isoform X1 [KO:K09091]
100466047  HEYL; hairy/enhancer-of-split related with YRPW motif-like protein isoform X1 [KO:K09091]
100474494  HEY1; hairy/enhancer-of-split related with YRPW motif protein 1 [KO:K09091]
100478767  FLT4; vascular endothelial growth factor receptor 3 isoform X3 [KO:K05097] [EC:2.7.10.1]
100481788  SHH; LOW QUALITY PROTEIN: sonic hedgehog protein [KO:K11988]
100475966  PTCH1; protein patched homolog 1 isoform X1 [KO:K06225]
100482729  SMO; smoothened homolog isoform X1 [KO:K06226]
100476891  KIF7; kinesin-like protein KIF7 [KO:K18806]
100483818  SUFU; suppressor of fused homolog isoform X1 [KO:K06229]
100478391  GLI1; zinc finger protein GLI1 [KO:K16797]
100484506  GLI2; zinc finger protein GLI2 [KO:K16798]
100463969  GLI3; transcriptional activator GLI3 isoform X4 [KO:K06230]
100465860  BMP2; bone morphogenetic protein 2 isoform X2 [KO:K21283]
100477715  BMP4; bone morphogenetic protein 4 isoform X1 [KO:K04662]
100476875  HHIP; hedgehog-interacting protein isoform X1 [KO:K06231]
100478607  PTCH2; protein patched homolog 2 isoform X1 [KO:K11101]
100464952  AR; androgen receptor [KO:K08557]
100471414  HSP90AB1; LOW QUALITY PROTEIN: heat shock protein HSP 90-beta [KO:K04079]
100467363  HSP90AA1; LOW QUALITY PROTEIN: heat shock protein HSP 90-alpha [KO:K04079]
117803466  LOW QUALITY PROTEIN: heat shock protein HSP 90-beta-like [KO:K04079]
100474020  HSP90B1; endoplasmin [KO:K09487]
Compound
C00027  Hydrogen peroxide
C00039  DNA
C00076  Calcium cation
C00122  Fumarate
C00149  (S)-Malate
C00165  Diacylglycerol
C00187  Cholesterol
C00280  Androstenedione
C00410  Progesterone
C00416  Phosphatidate
C00533  Nitric oxide
C00535  Testosterone
C00575  3',5'-Cyclic AMP
C00584  Prostaglandin E2
C00681  1-Acyl-sn-glycerol 3-phosphate
C00704  Superoxide
C00735  Cortisol
C00762  Cortisone
C00777  Retinoate
C00951  Estradiol-17beta
C01227  Dehydroepiandrosterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01471  Acrolein
C03917  Dihydrotestosterone
C05981  Phosphatidylinositol-3,4,5-trisphosphate
C07653  Flutamide
C15493  9-cis-Retinoic acid
C16038  2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
C16844  Hydroxyl radical
C21641  Hydroperoxyl radical
C21642  4-Hydroxynonenal
Reference
  Authors
Weinberg RA.
  Title
The biology of cancer
  Journal
Garland Science, Taylor & Francis Group, LLC (2007)
Reference
PMID:10647931
  Authors
Hanahan D, Weinberg RA
  Title
The hallmarks of cancer.
  Journal
Cell 100:57-70 (2000)
DOI:10.1016/S0092-8674(00)81683-9
Reference
PMID:15000146
  Authors
Grady WM.
  Title
Genomic instability and colon cancer.
  Journal
Cancer Metastasis Rev 23:11-27 (2004)
DOI:10.1023/A:1025861527711
Reference
PMID:16555243
  Authors
Soreide K, Janssen EA, Soiland H, Korner H, Baak JP.
  Title
Microsatellite instability in colorectal cancer.
  Journal
Br J Surg 93:395-406 (2006)
DOI:10.1002/bjs.5328
Reference
PMID:11078609
  Authors
Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB.
  Title
Hereditary non-polyposis colorectal cancer: an updated review.
  Journal
Eur J Surg Oncol 26:635-45 (2000)
DOI:10.1053/ejso.2000.0974
Reference
PMID:16699851
  Authors
Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y.
  Title
Colorectal cancer: genetics of development and metastasis.
  Journal
J Gastroenterol 41:185-92 (2006)
DOI:10.1007/s00535-006-1801-6
Reference
PMID:12621137
  Authors
Lynch HT, de la Chapelle A.
  Title
Hereditary colorectal cancer.
  Journal
N Engl J Med 348:919-32 (2003)
DOI:10.1056/NEJMra012242
Reference
PMID:12951588
  Authors
Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C.
  Title
The significance of unstable chromosomes in colorectal cancer.
  Journal
Nat Rev Cancer 3:695-701 (2003)
DOI:10.1038/nrc1165
Reference
PMID:10505543
  Authors
Behrens J.
  Title
Cadherins and catenins: role in signal transduction and tumor progression.
  Journal
Cancer Metastasis Rev 18:15-30 (1999)
DOI:10.1023/A:1006200102166
Reference
PMID:16042571
  Authors
Behrens J.
  Title
The role of the Wnt signalling pathway in colorectal tumorigenesis.
  Journal
Biochem Soc Trans 33:672-5 (2005)
DOI:10.1042/BST0330672
Reference
PMID:15349822
  Authors
Behrens J, Lustig B.
  Title
The Wnt connection to tumorigenesis.
  Journal
Int J Dev Biol 48:477-87 (2004)
DOI:10.1387/ijdb.041815jb
Reference
PMID:9196022
  Authors
Polakis P.
  Title
The adenomatous polyposis coli (APC) tumor suppressor.
  Journal
Biochim Biophys Acta 1332:F127-47 (1997)
DOI:10.1016/S0304-419X(97)00008-5
Reference
PMID:12737309
  Authors
Janssen KP.
  Title
Murine models of colorectal cancer: studying the role of oncogenic K-ras.
  Journal
Cell Mol Life Sci 60:495-506 (2003)
DOI:10.1007/s000180300041
Reference
PMID:11459867
  Authors
Adjei AA.
  Title
Blocking oncogenic Ras signaling for cancer therapy.
  Journal
J Natl Cancer Inst 93:1062-74 (2001)
DOI:10.1093/jnci/93.14.1062
Reference
PMID:15573119
  Authors
Arakawa H.
  Title
Netrin-1 and its receptors in tumorigenesis.
  Journal
Nat Rev Cancer 4:978-87 (2004)
DOI:10.1038/nrc1504
Reference
PMID:15310786
  Authors
Mehlen P, Fearon ER.
  Title
Role of the dependence receptor DCC in colorectal cancer pathogenesis.
  Journal
J Clin Oncol 22:3420-8 (2004)
DOI:10.1200/JCO.2004.02.019
Reference
PMID:11223406
  Authors
Peltomaki P.
  Title
DNA mismatch repair and cancer.
  Journal
Mutat Res 488:77-85 (2001)
DOI:10.1016/S1383-5742(00)00058-2
Reference
PMID:15711891
  Authors
Li F, Cao Y, Townsend CM Jr, Ko TC.
  Title
TGF-beta signaling in colon cancer cells.
  Journal
World J Surg 29:306-11 (2005)
DOI:10.1007/s00268-004-7813-6
Reference
PMID:11170304
  Authors
Roman C, Saha D, Beauchamp R.
  Title
TGF-beta and colorectal carcinogenesis.
  Journal
Microsc Res Tech 52:450-7 (2001)
DOI:10.1002/1097-0029(20010215)52:4<450::AID-JEMT1030>3.0.CO;2-O
Reference
PMID:16326109
  Authors
Watson AJ.
  Title
An overview of apoptosis and the prevention of colorectal cancer.
  Journal
Crit Rev Oncol Hematol 57:107-21 (2006)
DOI:10.1016/j.critrevonc.2005.06.005
Reference
PMID:15479695
  Authors
Watson AJ.
  Title
Apoptosis and colorectal cancer.
  Journal
Gut 53:1701-9 (2004)
DOI:10.1136/gut.2004.052704
Reference
PMID:11477132
  Authors
Houlston RS.
  Title
What we could do now: molecular pathology of colorectal cancer.
  Journal
Mol Pathol 54:206-14 (2001)
DOI:10.1136/mp.54.4.206
Reference
  Authors
Von Hoff D, Evans D, Hruban R (ed).
  Title
Pancreatic cancer
  Journal
Jones and Bartlett publishers (2005)
Reference
  Authors
Niitsu Y, Yokota J (ed).
  Title
[Oncogenes and Tumor Suppressor Genes for Medical Oncologist] (In Japanese)
  Journal
Nankodo (1999)
Reference
PMID:12459728
  Authors
Bardeesy N, DePinho RA.
  Title
Pancreatic cancer biology and genetics.
  Journal
Nat Rev Cancer 2:897-909 (2002)
DOI:10.1038/nrc949
Reference
PMID:11407945
  Authors
Bardeesy N, Sharpless NE, DePinho RA, Merlino G.
  Title
The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.
  Journal
Semin Cancer Biol 11:201-18 (2001)
DOI:10.1006/scbi.2000.0371
Reference
PMID:12946833
  Authors
Cowgill SM, Muscarella P.
  Title
The genetics of pancreatic cancer.
  Journal
Am J Surg 186:279-86 (2003)
DOI:10.1016/S0002-9610(03)00226-5
Reference
PMID:16702400
  Authors
Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA.
  Title
Genetics and biology of pancreatic ductal adenocarcinoma.
  Journal
Genes Dev 20:1218-49 (2006)
DOI:10.1101/gad.1415606
Reference
PMID:10740269
  Authors
Shields JM, Pruitt K, McFall A, Shaub A, Der CJ.
  Title
Understanding Ras: 'it ain't over 'til it's over'.
  Journal
Trends Cell Biol 10:147-54 (2000)
DOI:10.1016/S0962-8924(00)01740-2
Reference
PMID:12648469
  Authors
Holbro T, Civenni G, Hynes NE.
  Title
The ErbB receptors and their role in cancer progression.
  Journal
Exp Cell Res 284:99-110 (2003)
DOI:10.1016/S0014-4827(02)00099-X
Reference
PMID:14967450
  Authors
Marmor MD, Skaria KB, Yarden Y.
  Title
Signal transduction and oncogenesis by ErbB/HER receptors.
  Journal
Int J Radiat Oncol Biol Phys 58:903-13 (2004)
DOI:10.1016/j.ijrobp.2003.06.002
Reference
PMID:14586404
  Authors
DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW.
  Title
Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.
  Journal
Oncogene 22:7781-95 (2003)
DOI:10.1038/sj.onc.1206966
Reference
PMID:12545153
  Authors
Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K.
  Title
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.
  Journal
Oncogene 22:319-29 (2003)
DOI:10.1038/sj.onc.1206122
Reference
PMID:14580692
  Authors
Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, Eguchi T, Chijiiwa K, Tsuneyoshi M, Tanaka M.
  Title
Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.
  Journal
Cancer Lett 201:107-16 (2003)
DOI:10.1016/S0304-3835(03)00482-8
Reference
PMID:12079267
  Authors
Schmid RM.
  Title
Genetic basis of pancreatic cancer.
  Journal
Best Pract Res Clin Gastroenterol 16:421-33 (2002)
DOI:10.1053/bega.2002.0316
Reference
PMID:15774796
  Authors
Elliott RL, Blobe GC.
  Title
Role of transforming growth factor Beta in human cancer.
  Journal
J Clin Oncol 23:2078-93 (2005)
DOI:10.1200/JCO.2005.02.047
Reference
PMID:15823750
  Authors
Rudkin TM, Foulkes WD.
  Title
BRCA2: breaks, mistakes and failed separations.
  Journal
Trends Mol Med 11:145-8 (2005)
DOI:10.1016/j.molmed.2005.02.003
Reference
PMID:11707511
  Authors
Venkitaraman AR.
  Title
Functions of BRCA1 and BRCA2 in the biological response to DNA damage.
  Journal
J Cell Sci 114:3591-8 (2001)
Reference
PMID:15639402
  Authors
Soni D, King JA, Kaye AH, Hovens CM.
  Title
Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge.
  Journal
J Clin Neurosci 12:1-5 (2005)
DOI:10.1016/j.jocn.2004.04.001
Reference
PMID:12154354
  Authors
Zhu Y, Parada LF.
  Title
The molecular and genetic basis of neurological tumours.
  Journal
Nat Rev Cancer 2:616-26 (2002)
DOI:10.1038/nrc866
Reference
PMID:11253051
  Authors
Holland EC.
  Title
Gliomagenesis: genetic alterations and mouse models.
  Journal
Nat Rev Genet 2:120-9 (2001)
DOI:10.1038/35052535
Reference
PMID:16700615
  Authors
Bansal K, Liang ML, Rutka JT.
  Title
Molecular biology of human gliomas.
  Journal
Technol Cancer Res Treat 5:185-94 (2006)
DOI:10.1177/153303460600500302
Reference
  Authors
Tabuchi K (ed).
  Title
[Gliomas: Research and therapy] (In Japanese)
  Journal
Springer-Verlag Tokyo (2006)
Reference
PMID:12762887
  Authors
Kapoor GS, O'Rourke DM.
  Title
Mitogenic signaling cascades in glial tumors.
  Journal
Neurosurgery 52:1425-34; discussion 1434-5 (2003)
DOI:10.1227/01.NEU.0000065135.28143.39
Reference
PMID:16095998
  Authors
Hulleman E, Helin K.
  Title
Molecular mechanisms in gliomagenesis.
  Journal
Adv Cancer Res 94:1-27 (2005)
DOI:10.1016/S0065-230X(05)94001-3
Reference
PMID:11057895
  Authors
Schlessinger J.
  Title
Cell signaling by receptor tyrosine kinases.
  Journal
Cell 103:211-25 (2000)
DOI:10.1016/S0092-8674(00)00114-8
Reference
PMID:9643506
  Authors
Ng HK, Lam PY.
  Title
The molecular genetics of central nervous system tumors.
  Journal
Pathology 30:196-202 (1998)
DOI:10.1080/00313029800169236
Reference
PMID:12084351
  Authors
Knobbe CB, Merlo A, Reifenberger G.
  Title
Pten signaling in gliomas.
  Journal
Neuro-oncol 4:196-211 (2002)
DOI:10.1093/neuonc/4.3.196
Reference
PMID:16557281
  Authors
Kondo T, Ezzat S, Asa SL.
  Title
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
  Journal
Nat Rev Cancer 6:292-306 (2006)
DOI:10.1038/nrc1836
Reference
PMID:16551846
  Authors
Chiloeches A, Marais R.
  Title
Is BRAF the Achilles' Heel of thyroid cancer?
  Journal
Clin Cancer Res 12:1661-4 (2006)
DOI:10.1158/1078-0432.CCR-06-0051
Reference
PMID:16946003
  Authors
Reddi HV, McIver B, Grebe SK, Eberhardt NL
  Title
The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.
  Journal
Endocrinology 148:932-5 (2007)
DOI:10.1210/en.2006-0926
Reference
PMID:17062879
  Authors
Santoro M, Melillo RM, Fusco A.
  Title
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
  Journal
Eur J Endocrinol 155:645-653 (2006)
DOI:10.1530/eje.1.02289
Reference
PMID:16242838
  Authors
Pierotti MA, Greco A.
  Title
Oncogenic rearrangements of the NTRK1/NGF receptor.
  Journal
Cancer Lett 232:90-8 (2006)
DOI:10.1016/j.canlet.2005.07.043
Reference
PMID:16189702
  Authors
Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.
  Title
Molecular pathology of well-differentiated thyroid carcinomas.
  Journal
Virchows Arch 447:787-93 (2005)
DOI:10.1007/s00428-005-0065-5
Reference
PMID:11165748
  Authors
Gimm O.
  Title
Thyroid cancer.
  Journal
Cancer Lett 163:143-56 (2001)
DOI:10.1016/S0304-3835(00)00697-2
Reference
PMID:12094241
  Authors
Williams D.
  Title
Cancer after nuclear fallout: lessons from the Chernobyl accident.
  Journal
Nat Rev Cancer 2:543-9 (2002)
DOI:10.1038/nrc845
Reference
PMID:16236521
  Authors
Steffen B, Muller-Tidow C, Schwable J, Berdel WE, Serve H.
  Title
The molecular pathogenesis of acute myeloid leukemia.
  Journal
Crit Rev Oncol Hematol 56:195-221 (2005)
DOI:10.1016/j.critrevonc.2004.10.012
Reference
PMID:12563308
  Authors
Tenen DG.
  Title
Disruption of differentiation in human cancer: AML shows the way.
  Journal
Nat Rev Cancer 3:89-101 (2003)
DOI:10.1038/nrc989
Reference
PMID:16146838
  Authors
Choudhary C, Muller-Tidow C, Berdel WE, Serve H.
  Title
Signal transduction of oncogenic Flt3.
  Journal
Int J Hematol 82:93-9 (2005)
DOI:10.1532/IJH97.05090
Reference
PMID:12951584
  Authors
Stirewalt DL, Radich JP.
  Title
The role of FLT3 in haematopoietic malignancies.
  Journal
Nat Rev Cancer 3:650-65 (2003)
DOI:10.1038/nrc1169
Reference
PMID:16642045
  Authors
Martelli AM, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C, Cocco L.
  Title
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.
  Journal
Leukemia 20:911-28 (2006)
DOI:10.1038/sj.leu.2404245
Reference
PMID:15625120
  Authors
Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R.
  Title
Normal and oncogenic forms of the receptor tyrosine kinase kit.
  Journal
Stem Cells 23:16-43 (2005)
DOI:10.1634/stemcells.2004-0117
Reference
PMID:11721960
  Authors
Lorsbach RB, Downing JR.
  Title
The role of the AML1 transcription factor in leukemogenesis.
  Journal
Int J Hematol 74:258-65 (2001)
DOI:10.1007/BF02982058
Reference
PMID:12468433
  Authors
Mizuki M, Schwable J, Steur C, Choudhary C, Agrawal S, Sargin B, Steffen B, Matsumura I, Kanakura Y, Bohmer FD, Muller-Tidow C, Berdel WE, Serve H.
  Title
Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.
  Journal
Blood 101:3164-73 (2003)
DOI:10.1182/blood-2002-06-1677
Reference
PMID:17554387
  Authors
Mikesch JH, Steffen B, Berdel WE, Serve H, Muller-Tidow C.
  Title
The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.
  Journal
Leukemia 21:1638-47 (2007)
DOI:10.1038/sj.leu.2404732
Reference
PMID:16352814
  Authors
Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, Buergi U, Tenen DG.
  Title
ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.
  Journal
Blood 107:3330-8 (2006)
DOI:10.1182/blood-2005-07-3068
Reference
PMID:15719031
  Authors
Ren R.
  Title
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.
  Journal
Nat Rev Cancer 5:172-83 (2005)
DOI:10.1038/nrc1567
Reference
PMID:11071626
  Authors
Deininger MW, Goldman JM, Melo JV.
  Title
The molecular biology of chronic myeloid leukemia.
  Journal
Blood 96:3343-56 (2000)
Reference
PMID:14982876
  Authors
Calabretta B, Perrotti D.
  Title
The biology of CML blast crisis.
  Journal
Blood 103:4010-22 (2004)
DOI:10.1182/blood-2003-12-4111
Reference
PMID:10403855
  Authors
Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM.
  Title
The biology of chronic myeloid leukemia.
  Journal
N Engl J Med 341:164-72 (1999)
DOI:10.1056/NEJM199907153410306
Reference
PMID:15156182
  Authors
Mitani K.
  Title
Molecular mechanisms of leukemogenesis by AML1/EVI-1.
  Journal
Oncogene 23:4263-9 (2004)
DOI:10.1038/sj.onc.1207777
Reference
PMID:16484590
  Authors
Dong M, Blobe GC.
  Title
Role of transforming growth factor-beta in hematologic malignancies.
  Journal
Blood 107:4589-96 (2006)
DOI:10.1182/blood-2005-10-4169
Reference
PMID:9834202
  Authors
Kurokawa M, Mitani K, Imai Y, Ogawa S, Yazaki Y, Hirai H.
  Title
The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.
  Journal
Blood 92:4003-12 (1998)
Reference
PMID:12801837
  Authors
Brusa G, Benvenuti M, Mazzacurati L, Mancini M, Pattacini L, Martinelli G, Barbieri E, Greenberger JS, Baccarani M, Santucci MA.
  Title
p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.
  Journal
Haematologica 88:622-30 (2003)
Reference
PMID:11160144
  Authors
Baldwin AS.
  Title
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.
  Journal
J Clin Invest 107:241-6 (2001)
DOI:10.1172/JCI11991
Reference
PMID:12244301
  Authors
Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL.
  Title
PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.
  Journal
Nat Med 8:1145-52 (2002)
DOI:10.1038/nm759
Reference
PMID:15948971
  Authors
Tilli CM, Van Steensel MA, Krekels GA, Neumann HA, Ramaekers FC.
  Title
Molecular aetiology and pathogenesis of basal cell carcinoma.
  Journal
Br J Dermatol 152:1108-24 (2005)
DOI:10.1111/j.1365-2133.2005.06587.x
Reference
PMID:12588368
  Authors
Saldanha G, Fletcher A, Slater DN.
  Title
Basal cell carcinoma: a dermatopathological and molecular biological update.
  Journal
Br J Dermatol 148:195-202 (2003)
DOI:10.1046/j.1365-2133.2003.05151.x
Reference
PMID:15978322
  Authors
Daya-Grosjean L, Couve-Privat S.
  Title
Sonic hedgehog signaling in basal cell carcinomas.
  Journal
Cancer Lett 225:181-92 (2005)
DOI:10.1016/j.canlet.2004.10.003
Reference
PMID:15468170
  Authors
Tsai KY, Tsao H.
  Title
The genetics of skin cancer.
  Journal
Am J Med Genet C Semin Med Genet 131C:82-92 (2004)
DOI:10.1002/ajmg.c.30037
Reference
PMID:16881963
  Authors
Athar M, Tang X, Lee JL, Kopelovich L, Kim AL.
  Title
Hedgehog signalling in skin development and cancer.
  Journal
Exp Dermatol 15:667-77 (2006)
DOI:10.1111/j.1600-0625.2006.00473.x
Reference
PMID:16306523
  Authors
Rubin AI, Chen EH, Ratner D.
  Title
Basal-cell carcinoma.
  Journal
N Engl J Med 353:2262-9 (2005)
DOI:10.1056/NEJMra044151
Reference
PMID:11276000
  Authors
Saldanha G.
  Title
The Hedgehog signalling pathway and cancer.
  Journal
J Pathol 193:427-32 (2001)
DOI:10.1002/1096-9896(2000)9999:9999<::AID-PATH815>3.0.CO;2-N
Reference
PMID:15270885
  Authors
Saldanha G, Ghura V, Potter L, Fletcher A.
  Title
Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.
  Journal
Br J Dermatol 151:157-64 (2004)
DOI:10.1111/j.1365-2133.2004.06048.x
Reference
PMID:14737121
  Authors
Pasca di Magliano M, Hebrok M.
  Title
Hedgehog signalling in cancer formation and maintenance.
  Journal
Nat Rev Cancer 3:903-11 (2003)
DOI:10.1038/nrc1229
Reference
PMID:15656799
  Authors
Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, Scharwachter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G.
  Title
Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.
  Journal
Br J Dermatol 152:43-51 (2005)
DOI:10.1111/j.1365-2133.2005.06353.x
Reference
PMID:14556242
  Authors
Cohen MM Jr.
  Title
The hedgehog signaling network.
  Journal
Am J Med Genet A 123:5-28 (2003)
DOI:10.1002/ajmg.a.20495
Reference
PMID:11736900
  Authors
Yamazaki F, Aragane Y, Kawada A, Tezuka T.
  Title
Immunohistochemical detection for nuclear beta-catenin in sporadic basal cell carcinoma.
  Journal
Br J Dermatol 145:771-7 (2001)
DOI:10.1046/j.1365-2133.2001.04468.x
Reference
PMID:16054233
  Authors
Erb P, Ji J, Wernli M, Kump E, Glaser A, Buchner SA.
  Title
Role of apoptosis in basal cell and squamous cell carcinoma formation.
  Journal
Immunol Lett 100:68-72 (2005)
DOI:10.1016/j.imlet.2005.06.008
Reference
PMID:11130178
  Authors
Toftgard R.
  Title
Hedgehog signalling in cancer.
  Journal
Cell Mol Life Sci 57:1720-31 (2000)
DOI:10.1007/PL00000654
Reference
PMID:16822996
  Authors
Miller AJ, Mihm MC Jr.
  Title
Melanoma.
  Journal
N Engl J Med 355:51-65 (2006)
DOI:10.1056/NEJMra052166
Reference
PMID:12894244
  Authors
Chin L.
  Title
The genetics of malignant melanoma: lessons from mouse and man.
  Journal
Nat Rev Cancer 3:559-70 (2003)
DOI:10.1038/nrc1145
Reference
PMID:16750612
  Authors
Takata M, Saida T.
  Title
Genetic alterations in melanocytic tumors.
  Journal
J Dermatol Sci 43:1-10 (2006)
DOI:10.1016/j.jdermsci.2006.05.002
Reference
PMID:15841168
  Authors
Chudnovsky Y, Khavari PA, Adams AE.
  Title
Melanoma genetics and the development of rational therapeutics.
  Journal
J Clin Invest 115:813-24 (2005)
DOI:10.1172/JCI24808
Reference
PMID:16001050
  Authors
Merlino G.
  Title
Cancer biology: the weakest link?
  Journal
Nature 436:33-5 (2005)
DOI:10.1038/436033a
Reference
PMID:16001072
  Authors
Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR.
  Title
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
  Journal
Nature 436:117-22 (2005)
DOI:10.1038/nature03664
Reference
PMID:16899407
  Authors
Levy C, Khaled M, Fisher DE.
  Title
MITF: master regulator of melanocyte development and melanoma oncogene.
  Journal
Trends Mol Med 12:406-14 (2006)
DOI:10.1016/j.molmed.2006.07.008
Reference
PMID:15009714
  Authors
Tsao H, Goel V, Wu H, Yang G, Haluska FG.
  Title
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
  Journal
J Invest Dermatol 122:337-41 (2004)
DOI:10.1046/j.0022-202X.2004.22243.x
Reference
PMID:11224709
  Authors
Gruss C, Herlyn M.
  Title
Role of cadherins and matrixins in melanoma.
  Journal
Curr Opin Oncol 13:117-23 (2001)
DOI:10.1097/00001622-200103000-00006
Reference
PMID:15721476
  Authors
Thompson JF, Scolyer RA, Kefford RF.
  Title
Cutaneous melanoma.
  Journal
Lancet 365:687-701 (2005)
DOI:10.1016/S0140-6736(05)17951-3
Reference
PMID:14695152
  Authors
Omholt K, Platz A, Kanter L, Ringborg U, Hansson J.
  Title
NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.
  Journal
Clin Cancer Res 9:6483-8 (2003)
Reference
PMID:15557758
  Authors
Hussein MR.
  Title
The TP53 tumor suppressor gene and melanoma tumorigenesis: is there a relationship?
  Journal
Tumour Biol 25:200-7 (2004)
DOI:10.1159/000081103
Reference
PMID:10843728
  Authors
Lazar-Molnar E, Hegyesi H, Toth S, Falus A.
  Title
Autocrine and paracrine regulation by cytokines and growth factors in melanoma.
  Journal
Cytokine 12:547-54 (2000)
DOI:10.1006/cyto.1999.0614
Reference
PMID:16339096
  Authors
Cohen HT, McGovern FJ.
  Title
Renal-cell carcinoma.
  Journal
N Engl J Med 353:2477-90 (2005)
DOI:10.1056/NEJMra043172
Reference
PMID:15122209
  Authors
Pavlovich CP, Schmidt LS.
  Title
Searching for the hereditary causes of renal-cell carcinoma.
  Journal
Nat Rev Cancer 4:381-93 (2004)
DOI:10.1038/nrc1364
Reference
PMID:14634372
  Authors
Linehan WM, Walther MM, Zbar B.
  Title
The genetic basis of cancer of the kidney.
  Journal
J Urol 170:2163-72 (2003)
DOI:10.1097/01.ju.0000096060.92397.ed
Reference
PMID:14685170
  Authors
Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.
  Title
Met, metastasis, motility and more.
  Journal
Nat Rev Mol Cell Biol 4:915-25 (2003)
DOI:10.1038/nrm1261
Reference
PMID:15611513
  Authors
Kim WY, Kaelin WG.
  Title
Role of VHL gene mutation in human cancer.
  Journal
J Clin Oncol 22:4991-5004 (2004)
DOI:10.1200/JCO.2004.05.061
Reference
PMID:17211469
  Authors
Sudarshan S, Linehan WM, Neckers L.
  Title
HIF and fumarate hydratase in renal cancer.
  Journal
Br J Cancer 96:403-7 (2007)
DOI:10.1038/sj.bjc.6603547
Reference
PMID:17287871
  Authors
Sudarshan S, Pinto PA, Neckers L, Linehan WM.
  Title
Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.
  Journal
Nat Clin Pract Urol 4:104-10 (2007)
DOI:10.1038/ncpuro0711
Reference
PMID:12351585
  Authors
Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG.
  Title
Understanding familial and non-familial renal cell cancer.
  Journal
Hum Mol Genet 11:2489-98 (2002)
DOI:10.1093/hmg/11.20.2489
Reference
PMID:17158541
  Authors
Mitra AP, Datar RH, Cote RJ.
  Title
Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.
  Journal
J Clin Oncol 24:5552-64 (2006)
DOI:10.1200/JCO.2006.08.2073
Reference
PMID:16474624
  Authors
Wolff EM, Liang G, Jones PA.
  Title
Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.
  Journal
Nat Clin Pract Urol 2:502-10 (2005)
DOI:10.1038/ncpuro0318
Reference
PMID:16110317
  Authors
Wu XR.
  Title
Urothelial tumorigenesis: a tale of divergent pathways.
  Journal
Nat Rev Cancer 5:713-25 (2005)
DOI:10.1038/nrc1697
Reference
PMID:11103787
  Authors
Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R.
  Title
Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors.
  Journal
Cancer Res 60:6298-302 (2000)
Reference
PMID:12850530
  Authors
Bellmunt J, Hussain M, Dinney CP.
  Title
Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family.
  Journal
Crit Rev Oncol Hematol 46 Suppl:S85-104 (2003)
DOI:10.1016/S1040-8428(03)00067-2
Reference
PMID:17149381
  Authors
Sugano K, Kakizoe T.
  Title
Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.
  Journal
Nat Clin Pract Urol 3:642-52 (2006)
DOI:10.1038/ncpuro0649
Reference
PMID:15746962
  Authors
Dunn KL, Espino PS, Drobic B, He S, Davie JR.
  Title
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
  Journal
Biochem Cell Biol 83:1-14 (2005)
DOI:10.1139/o04-121
Reference
PMID:15551095
  Authors
Williams SG, Stein JP.
  Title
Molecular pathways in bladder cancer.
  Journal
Urol Res 32:373-85 (2004)
DOI:10.1007/s00240-003-0345-y
Reference
PMID:12878745
  Authors
Nelson WG, De Marzo AM, Isaacs WB.
  Title
Prostate cancer.
  Journal
N Engl J Med 349:366-81 (2003)
DOI:10.1056/NEJMra021562
Reference
PMID:15724144
  Authors
Li L, Ittmann MM, Ayala G, Tsai MJ, Amato RJ, Wheeler TM, Miles BJ, Kadmon D, Thompson TC.
  Title
The emerging role of the PI3-K-Akt pathway in prostate cancer progression.
  Journal
Prostate Cancer Prostatic Dis 8:108-18 (2005)
DOI:10.1038/sj.pcan.4500776
Reference
PMID:16551847
  Authors
Pienta KJ, Bradley D.
  Title
Mechanisms underlying the development of androgen-independent prostate cancer.
  Journal
Clin Cancer Res 12:1665-71 (2006)
DOI:10.1158/1078-0432.CCR-06-0067
Reference
PMID:11900250
  Authors
Feldman BJ, Feldman D.
  Title
The development of androgen-independent prostate cancer.
  Journal
Nat Rev Cancer 1:34-45 (2001)
DOI:10.1038/35094009
Reference
PMID:15082523
  Authors
Heinlein CA, Chang C.
  Title
Androgen receptor in prostate cancer.
  Journal
Endocr Rev 25:276-308 (2004)
DOI:10.1210/er.2002-0032
Reference
PMID:9422516
  Authors
Koivisto P, Kolmer M, Visakorpi T, Kallioniemi OP.
  Title
Androgen receptor gene and hormonal therapy failure of prostate cancer.
  Journal
Am J Pathol 152:1-9 (1998)
Reference
PMID:10835690
  Authors
Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, Feldman D.
  Title
Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.
  Journal
Nat Med 6:703-6 (2000)
DOI:10.1038/76287
Reference
PMID:10453277
  Authors
Macri E, Loda M.
  Title
Role of p27 in prostate carcinogenesis.
  Journal
Cancer Metastasis Rev 17:337-44 (1998)
DOI:10.1023/A:1006133620914
Reference
PMID:11750244
  Authors
Steers WD.
  Title
5alpha-reductase activity in the prostate.
  Journal
Urology 58:17-24; discussion 24 (2001)
DOI:10.1016/S0090-4295(01)01299-7
Reference
PMID:8069858
  Authors
Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF.
  Title
Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis.
  Journal
Cancer Res 54:4920-6 (1994)
Reference
PMID:11527574
  Authors
Grimes CA, Jope RS.
  Title
The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.
  Journal
Prog Neurobiol 65:391-426 (2001)
DOI:10.1016/S0301-0082(01)00011-9
Reference
PMID:15947972
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
PMID:14747944
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
PMID:16508724
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
PMID:17028294
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
PMID:11431710
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
PMID:15284264
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
PMID:16248975
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Reference
PMID:12711111
  Authors
Sanchez-Cespedes M.
  Title
Dissecting the genetic alterations involved in lung carcinogenesis.
  Journal
Lung Cancer 40:111-21 (2003)
DOI:10.1016/S0169-5002(03)00033-3
Reference
PMID:11720739
  Authors
Kaye FJ.
  Title
Molecular biology of lung cancer.
  Journal
Lung Cancer 34 Suppl 2:S35-41 (2001)
DOI:10.1016/S0169-5002(01)00342-7
Reference
PMID:12616528
  Authors
Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF.
  Title
Apoptosis and lung cancer: a review.
  Journal
J Cell Biochem 88:885-98 (2003)
DOI:10.1002/jcb.10440
Reference
PMID:11807782
  Authors
Sartorius UA, Krammer PH.
  Title
Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines.
  Journal
Int J Cancer 97:584-92 (2002)
DOI:10.1002/ijc.10096
Reference
PMID:16064138
  Authors
Adhikary S, Eilers M.
  Title
Transcriptional regulation and transformation by Myc proteins.
  Journal
Nat Rev Mol Cell Biol 6:635-45 (2005)
DOI:10.1038/nrm1703
Reference
PMID:11463388
  Authors
Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW, Reed SI.
  Title
A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.
  Journal
Mol Cell 7:639-50 (2001)
DOI:10.1016/S1097-2765(01)00210-6
Reference
PMID:15109562
  Authors
Buttery RC, Rintoul RC, Sethi T.
  Title
Small cell lung cancer: the importance of the extracellular matrix.
  Journal
Int J Biochem Cell Biol 36:1154-60 (2004)
DOI:10.1016/S1357-2725(03)00261-9
Reference
PMID:11559746
  Authors
Yamada KM, Araki M.
  Title
Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.
  Journal
J Cell Sci 114:2375-82 (2001)
Reference
PMID:11905738
  Authors
Rintoul RC, Sethi T.
  Title
The role of extracellular matrix in small-cell lung cancer.
  Journal
Lancet Oncol 2:437-42 (2001)
DOI:10.1016/S1470-2045(00)00421-6
Reference
PMID:12243753
  Authors
Ekedahl J, Joseph B, Grigoriev MY, Muller M, Magnusson C, Lewensohn R, Zhivotovsky B.
  Title
Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.
  Journal
Exp Cell Res 279:277-90 (2002)
DOI:10.1006/excr.2002.5608
Reference
PMID:12379883
  Authors
Osada H, Takahashi T.
  Title
Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
  Journal
Oncogene 21:7421-34 (2002)
DOI:10.1038/sj.onc.1205802
Reference
PMID:12741677
  Authors
Yokota J, Nishioka M, Tani M, Kohno T.
  Title
Genetic alterations responsible for metastatic phenotypes of lung cancer cells.
  Journal
Clin Exp Metastasis 20:189-93 (2003)
DOI:10.1023/a:1022978932215
Reference
PMID:16870043
  Authors
Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS.
  Title
K-ras mutations in non-small-cell lung carcinoma: a review.
  Journal
Clin Lung Cancer 8:30-8 (2006)
DOI:10.3816/CLC.2006.n.030
Reference
PMID:15948711
  Authors
Pfeifer GP, Dammann R.
  Title
Methylation of the tumor suppressor gene RASSF1A in human tumors.
  Journal
Biochemistry (Mosc) 70:576-83 (2005)
DOI:10.1007/s10541-005-0151-y
Reference
PMID:11902573
  Authors
Altucci L, Gronemeyer H.
  Title
The promise of retinoids to fight against cancer.
  Journal
Nat Rev Cancer 1:181-93 (2001)
DOI:10.1038/35106036
Reference
PMID:10944551
  Authors
Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF.
  Title
Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.
  Journal
J Natl Cancer Inst 92:1303-7 (2000)
DOI:10.1093/jnci/92.16.1303
Reference
PMID:12867060
  Authors
Hirsch FR, Scagliotti GV, Langer CJ, Varella-Garcia M, Franklin WA.
  Title
Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.
  Journal
Lung Cancer 41 Suppl 1:S29-42 (2003)
DOI:10.1016/S0169-5002(03)00137-5
Reference
PMID:16112428
  Authors
Panani AD, Roussos C.
  Title
Cytogenetic and molecular aspects of lung cancer.
  Journal
Cancer Lett 239:1-9 (2006)
DOI:10.1016/j.canlet.2005.06.030
Reference
PMID:12407699
  Authors
Mitsuuchi Y, Testa JR.
  Title
Cytogenetics and molecular genetics of lung cancer.
  Journal
Am J Med Genet 115:183-8 (2002)
DOI:10.1002/ajmg.10692
Reference
PMID:15942304
  Authors
Breuer RH, Postmus PE, Smit EF.
  Title
Molecular pathology of non-small-cell lung cancer.
  Journal
Respiration 72:313-30 (2005)
DOI:10.1159/000085376
Reference
PMID:11895903
  Authors
Piyathilake CJ, Frost AR, Manne U, Weiss H, Bell WC, Heimburger DC, Grizzle WE.
  Title
Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
  Journal
Clin Cancer Res 8:734-44 (2002)
Reference
PMID:16189154
  Authors
Awaya H, Takeshima Y, Furonaka O, Kohno N, Inai K.
  Title
Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
  Journal
J Clin Pathol 58:1076-80 (2005)
DOI:10.1136/jcp.2004.025585
Reference
PMID:21193867
  Authors
Lappano R, Maggiolini M
  Title
G protein-coupled receptors: novel targets for drug discovery in cancer.
  Journal
Nat Rev Drug Discov 10:47-60 (2011)
DOI:10.1038/nrd3320
Reference
PMID:24508914
  Authors
O'Hayre M, Degese MS, Gutkind JS
  Title
Novel insights into G protein and G protein-coupled receptor signaling in cancer.
  Journal
Curr Opin Cell Biol 27:126-35 (2014)
DOI:10.1016/j.ceb.2014.01.005
Reference
PMID:17251915
  Authors
Dorsam RT, Gutkind JS
  Title
G-protein-coupled receptors and cancer.
  Journal
Nat Rev Cancer 7:79-94 (2007)
DOI:10.1038/nrc2069
Related
pathway
aml03320  PPAR signaling pathway
aml04010  MAPK signaling pathway
aml04020  Calcium signaling pathway
aml04024  cAMP signaling pathway
aml04060  Cytokine-cytokine receptor interaction
aml04066  HIF-1 signaling pathway
aml04110  Cell cycle
aml04115  p53 signaling pathway
aml04150  mTOR signaling pathway
aml04151  PI3K-Akt signaling pathway
aml04210  Apoptosis
aml04310  Wnt signaling pathway
aml04330  Notch signaling pathway
aml04340  Hedgehog signaling pathway
aml04350  TGF-beta signaling pathway
aml04370  VEGF signaling pathway
aml04510  Focal adhesion
aml04512  ECM-receptor interaction
aml04520  Adherens junction
aml04630  JAK-STAT signaling pathway
aml04915  Estrogen signaling pathway
KO pathway
ko05200   
LinkDB

DBGET integrated database retrieval system